AU2023260921A1 - Serpin peptide derivatives and methods of using the same - Google Patents

Serpin peptide derivatives and methods of using the same Download PDF

Info

Publication number
AU2023260921A1
AU2023260921A1 AU2023260921A AU2023260921A AU2023260921A1 AU 2023260921 A1 AU2023260921 A1 AU 2023260921A1 AU 2023260921 A AU2023260921 A AU 2023260921A AU 2023260921 A AU2023260921 A AU 2023260921A AU 2023260921 A1 AU2023260921 A1 AU 2023260921A1
Authority
AU
Australia
Prior art keywords
amino acid
peptide derivative
serpin
serpin peptide
acid residues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023260921A
Other languages
English (en)
Inventor
Dana AUSTIN
Cohava Gelber
Cyrille Gineste
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SERPIN PHARMA LLC
Original Assignee
SERPIN PHARMA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SERPIN PHARMA LLC filed Critical SERPIN PHARMA LLC
Publication of AU2023260921A1 publication Critical patent/AU2023260921A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2023260921A 2022-04-29 2023-04-27 Serpin peptide derivatives and methods of using the same Pending AU2023260921A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263363840P 2022-04-29 2022-04-29
US63/363,840 2022-04-29
PCT/US2023/066321 WO2023212661A1 (en) 2022-04-29 2023-04-27 Serpin peptide derivatives and methods of using the same

Publications (1)

Publication Number Publication Date
AU2023260921A1 true AU2023260921A1 (en) 2024-11-07

Family

ID=88519894

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2023260921A Pending AU2023260921A1 (en) 2022-04-29 2023-04-27 Serpin peptide derivatives and methods of using the same

Country Status (9)

Country Link
US (1) US20250353898A1 (https=)
EP (1) EP4514838A1 (https=)
JP (1) JP2025515349A (https=)
CN (1) CN119497719A (https=)
AU (1) AU2023260921A1 (https=)
CA (1) CA3256966A1 (https=)
IL (1) IL316583A (https=)
MX (1) MX2024013323A (https=)
WO (1) WO2023212661A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439829A (en) * 1991-01-30 1995-08-08 Eli Lilly And Company Immobilization of biologically active molecules by changing the Oxidation state of a chelated transition metal ion
GB0916578D0 (en) * 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
CN102731626B (zh) * 2011-04-13 2014-10-01 中国人民解放军军事医学科学院毒物药物研究所 环肽及其医药用途
CA3077804C (en) * 2012-01-09 2023-07-25 Serpin Pharma, Llc Peptides and methods of using same
WO2013172954A1 (en) * 2012-05-17 2013-11-21 Ra Pharmaceuticals, Inc Peptide and peptidomimetic inhibitors
WO2016154041A1 (en) * 2015-03-20 2016-09-29 University Of Florida Research Foundation Incorporated Serpin reactive center loop peptides and methods of use
WO2021219896A1 (en) * 2020-05-01 2021-11-04 Atlas Biotechnology S.A. Treatment and/or prevention of a disease or a syndrome related to a virus infection
EP4003391A4 (en) * 2020-07-06 2023-02-22 Serpin Pharma, LLC PEPTIDES AND METHODS OF USE THEREOF

Also Published As

Publication number Publication date
EP4514838A1 (en) 2025-03-05
WO2023212661A1 (en) 2023-11-02
CN119497719A (zh) 2025-02-21
US20250353898A1 (en) 2025-11-20
CA3256966A1 (en) 2023-11-02
MX2024013323A (es) 2024-12-06
JP2025515349A (ja) 2025-05-14
IL316583A (en) 2024-12-01

Similar Documents

Publication Publication Date Title
US20240261364A1 (en) Peptides and methods of using the same
CN103476933B (zh) 白介素1受体的拮抗剂
US20100222280A1 (en) PEPTIDES WITH THE CAPACITY TO BIND TO TRANSFORMING GROWTH FACTOR beta 1 (TGF-beta 1)
US20110190215A1 (en) Therapeutic use of peptides
US20200085905A1 (en) Method of treating overweight or obesity comprising administering a pleurotus ostreatus mushroom extract or a composition comprising a pleurotus ostretus mushroom extract
CN104277092B (zh) 用于预防和/或治疗老年性痴呆的β片层阻断肽
JP2023509383A (ja) レトロインベルソペプチド
US20250353898A1 (en) Serpin peptide derivatives and methods of using the same
HK40121727A (zh) Serpin肽衍生物及其使用方法
US10400009B2 (en) β-sheet breaker peptide used for preventing and/or treating alzheimer's disease
CN117062617A (zh) 脑损伤的组合治疗
US20250161419A1 (en) Serpin peptides and methods of using the same
CN109369780B (zh) 一种四肽及其制备方法与用途
JP4778507B2 (ja) 化学療法誘発末梢性ニューロパシーの治療のためのｉｌ６ｒ／ｉｌ６キメラ
US20080311103A1 (en) Anti-Inflammatory Peptides and Methods of Use Thereof
HK40118659A (zh) Serpin肽及其使用方法
Xie Sanguinarine alleviates post-stroke cognitive impairment in rats by modulating the p38 MAPK signaling pathway: Sanguinarine improves post-stroke cognitive impairment
JP2025517506A (ja) トレフォイル因子２／インターフェロンα２融合タンパク質及びそのウイルス感染疾患の予防・治療における用途
US7829528B2 (en) Compositions and methods for treating STAT-6 associated diseases or conditions
TW202506704A (zh) 具有改善乾眼症活性的新型胜肽及包括其之藥物組合物
KR20170069997A (ko) 미리스토일화된 렙틴-관련된 펩티드 및 이들의 용도
KR20230068866A (ko) 결핵균의 Rv3364c 단백질에서 유래한 패혈증 치료용 펩타이드
KR20210145231A (ko) 짧은 합성 펩티드 및 망막 변성 질환 및/또는 조직 손상 치료를 위한 용도
Heskamp Role of CXCL12 and CXCR4 in axonal regeneration of mature retinal ganglion cells
Zhu Factors in glutamate excitotoxicity, inflammation and epilepsy